COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 2124: Articles 21231-21240  | Next

A 3D Structural Interactome to Explore the Impact of Evolutionary Divergence, Population Variation, and Small-molecule Drugs on SARS-CoV-2-Human Protein-Protein Interactions
Wierbowski, S. D., Liang, S., Chen, Y., Andre, N. M., Lipkin, S. M., Whittaker, G. R., Yu, H.
10.1101/2020.10.13.308676 — Posted: 2020-10-13
Structural impact on SARS-CoV-2 spike protein by D614G substitution
Zhang, J., Cai, Y., Xiao, T., Lu, J., Peng, H., Sterling, S. M., Walsh, R. M., Rits-Volloch, S., Sliz, P., Chen, B.
10.1101/2020.10.13.337980 — Posted: 2020-10-13
Degradation of SARS-CoV-2 receptor ACE2 by tobacco carcinogen-induced Skp2 in lung epithelial cells
Zhou, G.-B., Wang, G.-Z., Zhao, Q., Liang, F., Zhang, C., Zhang, H., Wang, J., Chen, Z.-Y., Wu, R., Yu, H., Sun, B.-B., Feng, R., Xu, K.-F.
10.1101/2020.10.13.337774 — Posted: 2020-10-13
Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19.
Clark, J. J., Penrice-Randal, R., Sharma, P., Kipar, A., Dong, X., Davidson, A. D., Kavanagh Williamson, M., Matthews, D. A., Turtle, L., Prince, T., Hughes, G., Patterson, E. I., Subramaniam, K., Sharp, J., McLaughlin, L., Zhou, E.-M., Turner, J. D., Marriott, A. E., Colombo, S., Pennington, S., Biagini, G., Owen, A., Hiscox, J. A., Stewart, J. P.
10.1101/2020.10.13.334532 — Posted: 2020-10-13
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies
Yan, R., Wang, R., Ju, B., Yu, J., Zhang, Y., Liu, N., Wang, J., Zhang, Q., Chen, P., Zhou, B., Li, Y., Zhang, S., Tian, L., Zhong, X., Cheng, L., Ge, X., Zhao, J., Wang, H.-w., Wang, X., Zhang, Z., Zhang, L., Zhou, Q.
10.1101/2020.10.13.336800 — Posted: 2020-10-13
Molecular characterization of SARS-CoV-2 from Bangladesh: Implications in genetic diversity, possible origin of the virus, and functional significance of the mutations
Rahman, M. M., Kader, S. B., Rizvi, S. M. S.
10.1101/2020.10.12.336099 — Posted: 2020-10-13
Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in recovered COVID-19 patients: studies based on cellular and structural biology analysis
Wu, F., Yan, R., Liu, M., Liu, Z., Wang, Y., Luan, D., Wu, K., Song, Z., Sun, T., Ma, Y., Zhang, Y., Wang, Q., Li, X., Ji, P., Li, Y., Li, C., Wu, Y., Ying, T., Wen, Y., Jiang, S., Zhu, T., Lu, L., Zhang, Y., Zhou, Q., Huang, J.
10.1101/2020.10.08.20209114 — Posted: 2020-10-13
Gargle-Direct: Extraction-Free Detection of SARS-CoV-2 using Real-time PCR (RT-qPCR) of Saline Gargle Rinse Samples
Tilley, P., Gadkar, V., Goldfarb, D. M., Young, V., Watson, N., Al-Rawahi, G. N., Srigley, J., Hoang, L., Lee, T., Prystajecky, N.
10.1101/2020.10.09.20203430 — Posted: 2020-10-13
Predicting mortality of individual COVID-19 patients: A multicenter Dutch cohort
Ottenhoff, M. C., Ramos, L. A., Potters, W., Janssen, M. L., Hubers, D., Pina-Fuentes, D., Thomas, R., van der Horst, I. C., Herff, C., Kubben, P., Elbers, P. W., Marquering, H. A., Welling, M., Hu, S., Simsek, S., de Kruif, M. D., Dorman, T., Fleuren, L. M., Schinkel, M., Noordzij, P. G., van den Bergh, J. P., Wyers, C. E., Buis, D. T., Wiersinga, J., van den Hout, E. H., Reidinga, A. C., Rusch, D., Sigaloff, K. C., Douma, R. A., de Haan, L., Fridgeirsson, E. A., Gritters van de Oever, N. C., Rennenberg, R. J., van Wingen, G., Aries, M. J., Beudel, M.
10.1101/2020.10.10.20210591 — Posted: 2020-10-13
Group Testing with Homophily to Curb Epidemics with Asymptomatic Carriers
de Belleville, L.-M. H.
10.1101/2020.10.09.20210260 — Posted: 2020-10-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).